Physician profile
William M Bauer
NPI 1902887276
$10,894.23
in general payments reported to CMS, 2019-2025
62 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,279 · 2020: $1,074 · 2021: $930 · 2022: $1,340 · 2023: $2,263 · 2024: $1,956 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,270.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,060.23 | 2019-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $973.25 | 2019-2025 | Farxiga, Lokelma, Breztri |
| Lilly USA, LLC | $916.94 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $904.92 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $736.77 | 2019-2024 | Rexulti, Nuedexta |
| Abbvie INC. | $363.38 | 2019-2024 | Qulipta |
| Sunovion Pharmaceuticals INC. | $328.75 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $305.09 | 2019-2025 | Austedo, Austedo Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $280.61 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $264.63 | 2022-2025 | |
| Abbott Laboratories | $226.76 | 2023-2025 | Freestyle Libre 3 |
| Neurocrine Biosciences, INC. | $220.22 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $209.55 | 2019-2023 | Verquvo |
| Neurelis, INC. | $190.28 | 2024 | Valtoco |
| Esperion Therapeutics, INC. | $187.60 | 2020-2024 | Nexletol |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.